Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Net Cash Flow of $24.5 million for Q1 2026, down 71.84% on a QoQ basis from $87.0 million in Q4 2025, and up 1086.51% year-over-year from $2.1 million in Q1 2025.
Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Net Cash Flow history runs 6 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- Quarterly Net Cash Flow rose 1086.51% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.0 million (up 1705.97% YoY) and the FY2025 annual result came in at $13.5 million, up 282.71% from the prior year.
- Net Cash Flow was $24.5 million for Q1 2026 at Canton Strategic Holdings, down from $87.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $87.0 million in Q4 2025 and bottomed at -$3.1 million in Q3 2024.
- A 5-year average of $7.0 million and a median of -$1.1 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 24095.05% — and 2025, when it jumped 7272.57%.
- Canton Strategic Holdings' Net Cash Flow stood at -$1.1 million in 2022, then surged by 859.23% to $8.2 million in 2023, then slumped by 114.71% to -$1.2 million in 2024, then soared by 7272.57% to $87.0 million in 2025, then slumped by 71.84% to $24.5 million in 2026.
- Business Quant data shows CNTN's Net Cash Flow at $24.5 million in Q1 2026, $87.0 million in Q4 2025, and $5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 24.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.50 Mn |
| Mar 31, 2026 | 24.50 Mn |
| Dec 31, 2025 | 86.99 Mn |
| Dec 31, 2025 | 86.99 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -531,463.00 |
| Jun 30, 2024 | -531,463.00 |
| Mar 31, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Dec 31, 2023 | 8.25 Mn |